201 related articles for article (PubMed ID: 20460162)
1. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
2. A two-dimensional multiwell cell culture method for the production of CYP3A4-expressing hepatocyte-like cells from HepaRG cells.
Ooeda K; Kubiura-Ichimaru M; Tsuji S; Okuyama S; Yamashita M; Mine A; Kawamura F; Ueyama T; Tada M
Pharmacol Res Perspect; 2020 Oct; 8(5):e00652. PubMed ID: 32955797
[TBL] [Abstract][Full Text] [Related]
3. Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study.
Bernasconi C; Pelkonen O; Andersson TB; Strickland J; Wilk-Zasadna I; Asturiol D; Cole T; Liska R; Worth A; Müller-Vieira U; Richert L; Chesne C; Coecke S
Toxicol In Vitro; 2019 Oct; 60():212-228. PubMed ID: 31158489
[TBL] [Abstract][Full Text] [Related]
4. Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug-induced liver injury.
Allard J; Bucher S; Ferron PJ; Launay Y; Fromenty B
Fundam Clin Pharmacol; 2024 Feb; 38(1):152-167. PubMed ID: 37665028
[TBL] [Abstract][Full Text] [Related]
5. Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro.
Nelson LJ; Treskes P; Howie AF; Walker SW; Hayes PC; Plevris JN
Sci Rep; 2013; 3():2735. PubMed ID: 24061220
[TBL] [Abstract][Full Text] [Related]
6. Direct and cytokine-mediated effects of albumin-fused growth hormone, TV-1106, on CYP enzyme expression in human hepatocytes in vitro.
Czerwiński M; Amunom I; Piryatinsky V; Hallak H; Sahly Y; Bar-Ilan O; Bolliger P; Bassan M
Pharmacol Res Perspect; 2018 Jun; 6(3):e00397. PubMed ID: 29721322
[TBL] [Abstract][Full Text] [Related]
7. [Long term maintenance of cytochrome P450 activity in a cell sheet-based three-dimensional human hepatic model].
Guan S; Gao B; Xiao J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2022 Aug; 39(4):776-783. PubMed ID: 36008342
[TBL] [Abstract][Full Text] [Related]
8. Efficient hepatocyte differentiation of primary human hepatocyte-derived organoids using three dimensional nanofibers (HYDROX) and their possible application in hepatotoxicity research.
Tong Y; Ueyama-Toba Y; Yokota J; Matsui H; Kanai M; Mizuguchi H
Sci Rep; 2024 May; 14(1):10846. PubMed ID: 38736008
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.
Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; Houdt JV; Lähteenmäki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
Toxicol Sci; 2018 Apr; 162(2):655-666. PubMed ID: 29329425
[TBL] [Abstract][Full Text] [Related]
10. Differentiated and non-differentiated HepaRG™ cells: A possible in-vitro model system for early hepatocarcinogenesis and non-genotoxic carcinogens.
Gutmann M; Stimpfl E; Langmann G; Koudelka H; Mir-Karner B; Grasl-Kraupp B
Toxicol Lett; 2023 Dec; 390():15-24. PubMed ID: 37890683
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.
Seo JE; Yu JZ; Xu H; Li X; Atrakchi AH; McGovern TJ; Bruno KLD; Mei N; Heflich RH; Guo X
Arch Toxicol; 2023 Oct; 97(10):2785-2798. PubMed ID: 37486449
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Human Long-Term Liver Models for Clearance Prediction of Slowly Metabolized Compounds.
Preiss LC; Georgi K; Lauschke VM; Petersson C
Drug Metab Dispos; 2024 May; 52(6):539-547. PubMed ID: 38604730
[TBL] [Abstract][Full Text] [Related]
13. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines.
van Wenum M; Adam AA; Hakvoort TB; Hendriks EJ; Shevchenko V; van Gulik TM; Chamuleau RA; Hoekstra R
Int J Biol Sci; 2016; 12(8):964-78. PubMed ID: 27489500
[TBL] [Abstract][Full Text] [Related]
14. Association between low body weight and cytochrome P-450 enzyme activity in patients with anorexia nervosa.
Sandvik P; Lydersen S; Hegstad S; Spigset O
Pharmacol Res Perspect; 2020 Jun; 8(3):e00615. PubMed ID: 32529756
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants.
Faccioli LAP; Cetin Z; Kocas-Kilicarslan ZN; Ortiz K; Sun Y; Hu Z; Kurihara T; Tafaleng EN; Florentino RM; Wang Z; Xia M; Miedel MT; Taylor DL; Behari J; Ostrowska A; Constantine R; Li A; Soto-Gutierrez A
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686209
[TBL] [Abstract][Full Text] [Related]
16. Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines.
Boon R; Kumar M; Tricot T; Elia I; Ordovas L; Jacobs F; One J; De Smedt J; Eelen G; Bird M; Roelandt P; Doglioni G; Vriens K; Rossi M; Vazquez MA; Vanwelden T; Chesnais F; El Taghdouini A; Najimi M; Sokal E; Cassiman D; Snoeys J; Monshouwer M; Hu WS; Lange C; Carmeliet P; Fendt SM; Verfaillie CM
Nat Commun; 2020 Mar; 11(1):1393. PubMed ID: 32170132
[TBL] [Abstract][Full Text] [Related]
17. Oxygen drives hepatocyte differentiation and phenotype stability in liver cell lines.
van Wenum M; Adam AAA; van der Mark VA; Chang JC; Wildenberg ME; Hendriks EJ; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RP; Chamuleau RAFM; Hoekstra R
J Cell Commun Signal; 2018 Sep; 12(3):575-588. PubMed ID: 29399736
[TBL] [Abstract][Full Text] [Related]
18. Undifferentiated HepaRG cells show reduced sensitivity to the toxic effects of M8OI through a combination of CYP3A7-mediated oxidation and a reduced reliance on mitochondrial function.
Abdelghany TM; Hedya SA; Charlton A; Aljehani FA; Alanazi K; Budastour AA; Marin L; Wright MC
Food Chem Toxicol; 2024 Jun; 188():114681. PubMed ID: 38677401
[TBL] [Abstract][Full Text] [Related]
19. Development of a human liver microphysiological coculture system for higher throughput chemical safety assessment.
Ip BC; Madnick SJ; Zheng S; van Tongeren TCA; Hall SJ; Li H; Martin S; Spriggs S; Carmichael P; Chen W; Ames D; Breitweiser LA; Pence HE; Bowling AJ; Johnson KJ; Cubberley R; Morgan JR; Boekelheide K
Toxicol Sci; 2024 May; 199(2):227-245. PubMed ID: 38335931
[TBL] [Abstract][Full Text] [Related]
20. Suitability of human HepaRG cells and liver spheroids as in vitro model to investigate the bioactivation of the organothiophosphate pesticide parathion.
Horn G; Worek F
Toxicol In Vitro; 2024 May; 97():105811. PubMed ID: 38521251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
